Acorah Software Products - Accounts Production 19.2.450 false true 31 January 2025 1 February 2024 false 1 February 2025 31 January 2026 31 January 2026 10282578 Mr Tabarak Sadik iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10282578 2025-01-31 10282578 2026-01-31 10282578 2025-02-01 2026-01-31 10282578 frs-core:CurrentFinancialInstruments 2026-01-31 10282578 frs-core:Non-currentFinancialInstruments 2026-01-31 10282578 frs-core:ShareCapital 2026-01-31 10282578 frs-core:RetainedEarningsAccumulatedLosses 2026-01-31 10282578 frs-bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 10282578 frs-bus:FilletedAccounts 2025-02-01 2026-01-31 10282578 frs-bus:SmallEntities 2025-02-01 2026-01-31 10282578 frs-bus:AuditExempt-NoAccountantsReport 2025-02-01 2026-01-31 10282578 frs-bus:SmallCompaniesRegimeForAccounts 2025-02-01 2026-01-31 10282578 frs-core:UnlistedNon-exchangeTraded 2026-01-31 10282578 frs-core:UnlistedNon-exchangeTraded 2025-01-31 10282578 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2025-01-31 10282578 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2026-01-31 10282578 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2025-01-31 10282578 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2026-01-31 10282578 frs-bus:Director1 2025-02-01 2026-01-31 10282578 frs-countries:EnglandWales 2025-02-01 2026-01-31 10282578 2024-01-31 10282578 2025-01-31 10282578 2024-02-01 2025-01-31 10282578 frs-core:CurrentFinancialInstruments 2025-01-31 10282578 frs-core:Non-currentFinancialInstruments 2025-01-31 10282578 frs-core:ShareCapital 2025-01-31 10282578 frs-core:RetainedEarningsAccumulatedLosses 2025-01-31
Registered number: 10282578
Vivo Healthcare Limited
Unaudited Financial Statements
For The Year Ended 31 January 2026
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—4
Page 1
Balance Sheet
Registered number: 10282578
2026 2025
Notes £ £ £ £
FIXED ASSETS
Investments 4 1,569,284 1,569,284
1,569,284 1,569,284
CURRENT ASSETS
Cash at bank and in hand 770 1,285
770 1,285
Creditors: Amounts Falling Due Within One Year 5 (272,171 ) (253,068 )
NET CURRENT ASSETS (LIABILITIES) (271,401 ) (251,783 )
TOTAL ASSETS LESS CURRENT LIABILITIES 1,297,883 1,317,501
Creditors: Amounts Falling Due After More Than One Year 6 (1,121,492 ) (1,160,500 )
NET ASSETS 176,391 157,001
CAPITAL AND RESERVES
Called up share capital 7 100 100
Profit and Loss Account 176,291 156,901
SHAREHOLDERS' FUNDS 176,391 157,001
Page 1
Page 2
For the year ending 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Tabarak Sadik
Director
30/09/2026
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Vivo Healthcare Limited is a private company, limited by shares, incorporated in England & Wales, registered number 10282578 . The registered office is 280 East Barnet Road, East Barnet, London, Barnet, EN4 8TD.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2025: 1)
1 1
4. Investments
Unlisted
£
Cost or Valuation
As at 1 February 2025 1,569,284
As at 31 January 2026 1,569,284
Provision
As at 1 February 2025 -
As at 31 January 2026 -
Net Book Value
As at 31 January 2026 1,569,284
As at 1 February 2025 1,569,284
5. Creditors: Amounts Falling Due Within One Year
2026 2025
£ £
Bank loans and overdrafts 37,001 37,001
Amounts owed to group undertakings 172,275 151,672
Other creditors 62,895 64,395
272,171 253,068
Page 3
Page 4
6. Creditors: Amounts Falling Due After More Than One Year
2026 2025
£ £
Bank loans 321,492 360,500
Other creditors 400,000 400,000
Amounts owed to group undertakings 400,000 400,000
1,121,492 1,160,500
7. Share Capital
2026 2025
£ £
Allotted, Called up and fully paid 100 100
Page 4